Clinical trial
Cancer Moonshot Biobank Research Protocol
NCT04314401 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cancer Moonshot Biobank Research Protocol
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 11, 2020
- Completion date
- April 30, 2027
- Enrollment
- 1,600 (estimated)
- Sites
- 150
Conditions
As the registry lists them; a condition with its own page is linked.
acute myeloid leukemia, anatomic stage iii breast cancer ajcc v8, anatomic stage iv breast cancer ajcc v8, clinical stage iv esophageal adenocarcinoma ajcc v8, clinical stage iv gastric cancer ajcc v8, clinical stage iv gastroesophageal junction adenocarcinoma ajcc v8, esophageal carcinoma, fallopian tube carcinoma, gastric carcinoma, hormone receptor-positive breast carcinoma, invasive breast carcinoma, lung non-small cell carcinoma, lung small cell carcinoma, malignant solid neoplasm, melanoma, metastatic prostate carcinoma, multiple myeloma, ovarian carcinoma, ovarian high grade serous adenocarcinoma, primary peritoneal carcinoma, stage iii fallopian tube cancer ajcc v8, stage iii lung cancer ajcc v8, stage iii ovarian cancer ajcc v8, stage iv colorectal cancer ajcc v8, stage iv fallopian tube cancer ajcc v8, stage iv lung cancer ajcc v8, stage iv ovarian cancer ajcc v8, stage ivb prostate cancer ajcc v8, triple-negative breast carcinoma